{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T04:25:26Z","timestamp":1686716726621},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,6,13]]},"DOI":"10.1001\/jama.2023.7395","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T15:02:01Z","timestamp":1686668521000},"page":"1987","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin Discontinuation in Pregnancies at High Risk of Preterm Preeclampsia"],"prefix":"10.1001","volume":"329","author":[{"given":"Jacqueline G.","family":"Parchem","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baha M.","family":"Sibai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"7","key":"jle230038r1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jama.2023.0691","article-title":"Aspirin discontinuation at 24 to 28 weeks\u2019 gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial.","volume":"329","author":"Mendoza","year":"2023","journal-title":"JAMA"},{"issue":"10220","key":"jle230038r2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"jle230038r3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis.","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"jle230038r4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004659.pub3","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications.","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"jle230038r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019.","volume":"5","author":"Wheeler","year":"2022","journal-title":"JAMA Netw Open"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2805913\/jama_parchem_2023_le_230038_1686241006.80972.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T15:02:05Z","timestamp":1686668525000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2805913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":5,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,6,13]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.7395","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,13]]}}}